Rivastigmine tartrate | Radio Compass News | PharmaCompass.com

Grow Your Pharma Business Digitally

X

Market Place

Sourcing support

Sourcing Support

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

All News Rivastigmine Tartrate

Breckenridge Announces Final Approval of its ANDA for Rivastigmine

02 Dec 2019 //

PR NEWSWIRE

Enforcement Report - Week of April 12, 2017

12 Apr 2017 //

FDA

Cadila Pharms Ltd`s Generic Rivastigmine Tartrate Receives Approval In US

13 Feb 2017 //

FDA

Aurobindo Pharma`s Generic Rivastigmine Tartrate approved in US for alzheimer

25 Mar 2016 //

FDA

Development of a novel dry powder inhalation formulation for the delivery of rivastigmine hydrogen tartrate

04 Feb 2016 //

PHARMA-EXCIPIENTS

Dr Reddy`s Lab slips on recall of Rivastigmine Tartrate Capsules from USA

24 Aug 2015 //

BUSINESS STANDARD

Orchid`s Generic Rivastigmine Tartrate (1.5, 3, 4.5, 6 Mg Base) Approved in US For Alzheimer

11 Jun 2015 //

FDA